Bifogade filer
Kurs
+4,03%
Likviditet
1,30 MSEK
Kalender
Tid* | ||
2025-11-20 | N/A | Årsstämma |
2025-11-14 | 09:00 | Kvartalsrapport 2026-Q1 |
2025-08-28 | 08:30 | Bokslutskommuniké 2025 |
2025-05-22 | 09:00 | Kvartalsrapport 2025-Q3 |
2025-02-13 | 09:00 | Kvartalsrapport 2025-Q2 |
2024-11-22 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2024-11-21 | - | Årsstämma |
2024-11-15 | - | Kvartalsrapport 2025-Q1 |
2024-08-28 | - | Bokslutskommuniké 2024 |
2024-05-24 | - | Kvartalsrapport 2024-Q3 |
2024-02-22 | - | Kvartalsrapport 2024-Q2 |
2023-12-14 | - | Extra Bolagsstämma 2024 |
2023-11-24 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2023-11-23 | - | Årsstämma |
2023-11-17 | - | Kvartalsrapport 2024-Q1 |
2023-08-28 | - | Bokslutskommuniké 2023 |
2023-05-26 | - | Kvartalsrapport 2023-Q3 |
2023-05-17 | - | Extra Bolagsstämma 2023 |
2023-02-23 | - | Kvartalsrapport 2023-Q2 |
2022-11-25 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2022-11-24 | - | Årsstämma |
2022-11-11 | - | Kvartalsrapport 2023-Q1 |
2022-08-26 | - | Bokslutskommuniké 2022 |
2022-05-20 | - | Kvartalsrapport 2022-Q3 |
2022-02-25 | - | Kvartalsrapport 2022-Q2 |
2021-11-26 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2021-11-25 | - | Årsstämma |
2021-11-11 | - | Kvartalsrapport 2022-Q1 |
2021-08-27 | - | Bokslutskommuniké 2021 |
2021-06-17 | - | Extra Bolagsstämma 2022 |
2021-05-21 | - | Kvartalsrapport 2021-Q3 |
2021-03-02 | - | Extra Bolagsstämma 2021 |
2021-02-26 | - | Kvartalsrapport 2021-Q2 |
2020-11-27 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2020-11-26 | - | Årsstämma |
2020-11-12 | - | Kvartalsrapport 2021-Q1 |
2020-08-28 | - | Bokslutskommuniké 2020 |
2020-05-22 | - | Kvartalsrapport 2020-Q3 |
2020-02-28 | - | Kvartalsrapport 2020-Q2 |
2019-11-22 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2019-11-21 | - | Årsstämma |
2019-11-08 | - | Kvartalsrapport 2020-Q1 |
2019-08-30 | - | Bokslutskommuniké 2019 |
2019-05-17 | - | Kvartalsrapport 2019-Q3 |
2019-02-15 | - | Kvartalsrapport 2019-Q2 |
2018-11-16 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2018-11-15 | - | Årsstämma |
2018-11-09 | - | Kvartalsrapport 2019-Q1 |
2018-08-30 | - | Bokslutskommuniké 2018 |
2018-05-18 | - | Kvartalsrapport 2018-Q3 |
2018-02-16 | - | Kvartalsrapport 2018-Q2 |
2017-11-10 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2017-11-09 | - | Årsstämma |
2017-11-02 | - | Kvartalsrapport 2018-Q1 |
2017-08-18 | - | Bokslutskommuniké 2017 |
2017-05-12 | - | Kvartalsrapport 2017-Q3 |
2017-02-10 | - | Kvartalsrapport 2017-Q2 |
2017-01-19 | - | Extra Bolagsstämma 2018 |
2016-11-18 | - | Kvartalsrapport 2017-Q1 |
2016-11-11 | - | X-dag ordinarie utdelning HAMLET B 0.00 SEK |
2016-11-10 | - | Årsstämma |
2016-08-19 | - | Bokslutskommuniké 2016 |
2016-05-13 | - | Kvartalsrapport 2016-Q3 |
2016-02-12 | - | Kvartalsrapport 2016-Q2 |
2015-11-13 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Bioteknik |
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participation in The Global Forum 2024 By BioStock, set to take place in Lund, Sweden, on May 29-30, 2024. The company will present at 3 pm on Thursday the 30[th] of May.
The Global Forum 2024 by BioStock is a premier international event in the life science industry, bringing together industry leaders, researchers, investors, and entrepreneurs to discuss the latest advancements and innovations in biotechnology and medical research. The forum provides a unique platform for networking, knowledge exchange, and business development, with a focus on promoting global collaboration and investment in future medical solutions. Hamlet BioPharma is proud to participate in this prestigious event and looks forward to contributing to the important discussions and opportunities that The Global Forum 2024 offers.
For more information about The Global Forum 2024 By BioStock, please visit The Global Forum 2024 (https://www.biostock.se/biostockglobalforum2024/) web page.
For further information, please contact:
Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com
Martin Erixon, CEO Hamlet BioPharma, +46-733 00 43 77
martin.erixon@hamletpharma.com
www.hamletbiopharma.com